HDFC Pharma and Healthcare Fund - Direct - Growth

A Equity Scheme by HDFC Asset Management Company Limited

1Y Returns (CAGR)
18.32%
Expense Ratio
0.93%

as of 01/03/2026

AUM
₹644.16 Cr

Qtr End: Mar 26

NAV
₹19.85

as of 03/06/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M9.97%46.23%16.45%
6M11.32%23.91%15.37%
1Y18.32%18.32%13.43%
3YN/AN/AN/A
5YN/AN/AN/A
Scheme Details
Launch Date
14/09/2023
Fund Age
2.7 years
Minimum Investment
₹100
Fund House
HDFC Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions